Petercam Founded 1919
Founders
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$23M
Portfolio companies 1
Rounds per year 0.01
Lead investments -
Follow on index
info
How often the fund supports its portfolio startups at next rounds
-
Exits -
Key employees -
Areas of investment
Biotechnology
Health Diagnostics
Medical Device
Summary

In 1919 was created Petercam, which is appeared as VC. The main office of represented VC is situated in the Brussels. The venture was found in Europe in Belgium.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight MDxHealth. We can highlight the next thriving fund investment areas, such as Biotechnology, Health Diagnostics. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Petercam, startups are often financed by Idinvest Partners. The meaningful sponsors for the fund in investment in the same round are Valiance Asset Management, Biovest International. In the next rounds fund is usually obtained by EASME - EU Executive Agency for SMEs.

The top activity for fund was in 2013. The top amount of exits for fund were in 2006. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 10 - 50 millions dollars.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
MDxHealth
Biotechnology
Health Diagnostics
Medical Device
Post-IPO Equity
23M25 Jun 2013 United States, Irvine
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Petercam?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: